{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Buffalo Grove",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88457",
      "recalling_firm": "XELLIA PHARMACEUTICALS USA, LLC",
      "address_1": "2150 E Lake Cook Rd",
      "address_2": "N/A",
      "postal_code": "60089-1862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA",
      "recall_number": "D-0756-2021",
      "product_description": "Micafungin for Injection, 50 mg/vial, Single-Dose Vial, Sterile, Rx Only, For Intravenous Infusion Only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089.  NDC 70594-036-01",
      "product_quantity": "9,161 vials 50 mg and 100 mg vials total",
      "reason_for_recall": "Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.",
      "recall_initiation_date": "20210806",
      "center_classification_date": "20210820",
      "termination_date": "20240929",
      "report_date": "20210901",
      "code_info": "Lot 467111, exp 1/2023"
    }
  ]
}